Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening

Cancer Cytopathology

Volumn 122, Issue 12, 2014, Pages 914-920

  Wentzensen, Nicolas ^a   Fetterman, Barbara ^b   Tokugawa, Diane ^b   Schiffman, Mark ^a   Castle, Philip E ^c   Wood, Shannon N ^a   Stiemerling, Eric ^b   Poitras, Nancy ^b   Lorey, Thomas ^b   Kinney, Walter ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c Global Coalition Against Cervical Cancer   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

cervical cancer screening; cytology; human papillomavirus; Ki 67; p16; Papanicolaou test; reproducibility

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16; P16 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STAINING; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYTODIAGNOSIS; EARLY DIAGNOSIS; FOLLOW UP; ISOLATION AND PURIFICATION; METABOLISM; OBSERVER VARIATION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; STANDARD; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; NEOPLASM GRADING; NEOPLASM PROTEINS; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84923795635     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21473     Document Type: Article

References (16)

1. Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J.Clin. 2012; 62: 147-172.
2. Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study [serial online]. BMJ. 2008; 337: a1754.
3. Katki HA, Kinney WK, Fetterman B, et al. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011; 12: 663-672.
4. Bergeron C, Ronco G, Reuschenbach M, et al. The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: an update of recent developments [published online ahead of print April 17, 2013]. Int J Cancer. 2014.
5. Carozzi F, Gillio-Tos A, Confortini M, et al. Risk of high grade CIN on follow up in HPV positive women according to baseline p16-INK4A results: prospective analysis of a sub-study nested in a randomised controlled trial. Lancet Oncol. 2013; 14: 168-176.
6. Wentzensen N,. Triage of HPV-positive women in cervical cancer screening. Lancet Oncol. 2013; 14: 107-109.
7. Wentzensen N, von Knebel DM,. Biomarkers in cervical cancer screening. Dis Markers. 2007; 23: 315-330.
8. Wentzensen N, Bergeron C, Cas F, Eschenbach D, Vinokurova S, von Knebel DM,. Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples. Cancer. 2005; 105: 461-467.
9. Ikenberg H, Bergeron C, Schmidt D, et al. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst. 2013; 105: 1550-1557.
10. Petry KU, Schmidt D, Scherbring S, et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology. Gynecol Oncol. 2011; 121: 505-509.
11. Schmidt D, Bergeron C, Denton KJ, Ridder R,. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol. 2011; 119: 158-166.
12. Wentzensen N, Schwartz L, Zuna RE, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012; 18: 4154-4162.
13. Stoler MH, Schiffman M,. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001; 285: 1500-1505.
14. Wentzensen N, Bergeron C, Cas F, Vinokurova S, von Knebel DM,. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia. Cancer. 2007; 111: 58-66.
15. Grabe N, Lahrmann B, Pommerencke T, von Knebel DM, Reuschenbach M, Wentzensen N,. A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides. Cell Oncol. 2010; 32: 109-119.
16. Lahrmann B, Valous NA, Eisenmann U, Wentzensen N, Grabe N,. Semantic focusing allows fully automated single-layer slide scanning of cervical cytology slides [serial online]. PLoS.One. 2013; 8: e61441.